DGX

Quest Diagnostics (DGX) P/E Ratio
P/E Ratio as of Oct 29, 2026: 25.18
Average24.41
Median24.46
Minimum23.36
Maximum25.37
25.18
0.57 (2.32%)past month
The P/E ratio for Quest Diagnostics (DGX) is 25.18 as of Oct 29, 2026. This represents a increase of 11.22% compared to its 12-month average P/E ratio of 22.64. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Quest Diagnostics P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Quest Diagnostics’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Quest Diagnostics to industry peers.
Quest Diagnostics P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Quest Diagnostics’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Quest Diagnostics to industry peers.
Quest Diagnostics (DGX) P/E Ratio Insights
See Quest Diagnostics’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Quest Diagnostics (DGX)
Order type
Buy in
Order amount
Est. shares
0 shares
Quest Diagnostics (DGX) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Oct 1, 2026 | $231.09 | 24.51 |
| Sep 1, 2026 | $236.22 | 25.06 |
| Aug 3, 2026 | $231.95 | 24.60 |
| Jul 1, 2026 | $216.02 | 23.83 |
| Jun 1, 2026 | $192.20 | 21.20 |
| May 1, 2026 | $192.67 | 21.25 |
| Apr 1, 2026 | $197.69 | 22.56 |
| Mar 2, 2026 | $210.25 | 23.99 |
| Feb 2, 2026 | $185.00 | 21.71 |
| Jan 2, 2026 | $173.79 | 20.39 |
Quest Diagnostics (DGX) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | 25.18 | +23.67% |
| 2025 | 20.36 | +0.54% |
| 2024 | 20.25 | -2.08% |
| 2023 | 20.68 | +34.11% |
| 2022 | 15.42 | +38.54% |
| 2021 | 11.13 | — |
FAQs About Quest Diagnostics (DGX) P/E ratio
The latest P/E ratio of Quest Diagnostics (DGX) is 25.18, as of Oct 29, 2026. This is calculated based on its current stock price and earnings per share (EPS).
Quest Diagnostics’s last 12-month average P/E ratio is 22.64, compared to its current P/E ratio of 25.18. This reflects a increase of 11.22%.
Quest Diagnostics’s current P/E ratio of 25.18 is higher than its last 12-month average P/E of 22.64. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Quest Diagnostics’s average P/E ratio over the last 3 years is 21.11. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Quest Diagnostics’s average P/E ratio over the last 5 years is 18.37. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.
Quest Diagnostics (DGX) P/E Ratio Insights
See Quest Diagnostics’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Quest Diagnostics (DGX)
Order type
Buy in
Order amount
Est. shares
0 shares
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.